pharmaphorum

JUNE 14, 2021

Rebecca Sanders from Lipodystrophy UK tells us how the patient voice helped convince NICE to approve a much-needed drug for this rare disease, and explores how regulators and pharma companies can help make patient involvement in HTA more impactful. This article appears in our free digital magazine Deep Dive: Market Access 2021.

Drugs 100

Drugs Pharma Companies Licensing Licensing 100

pharmaphorum

JANUARY 24, 2022

. “The cost of developing a new drug is extortionately high,” said Landray, adding that a very large proportion of those costs is in phase 3, and that means many promising therapies may never be taken forward by pharma companies.

Trials 95

Trials Drugs Clinical Trials Clinical Trials 95

pharmaphorum

JULY 8, 2022

“They can solve some immediate challenges with participation in research by conducting eCOA (electronic clinical outcome assessment) remotely or doing virtual visits. We have also seen the regulators actively support the use of these hybrid decentralised research approaches. Novel digital endpoints.

Clinical Trials 93

Clinical Trials Clinical Trials Trials Regulation 93

pharmaphorum

JUNE 8, 2021

Dr Jay Mei from Antengene tells us how the Asia Pacific region is opening up to innovative pharma companies, and gives tips for companies navigating this enormous market. At the same time, lots of people with experience at multinational pharmaceutical companies have chosen to return home. About the interviewee.

Marketing 105

Marketing Drugs Regulation Development 105

Drug Discovery World

SEPTEMBER 28, 2022

Its application in pharma, most commonly in drug discovery, has been steadily growing with global partnerships between tech vendors and pharma companies becoming more commonplace. Biotech and AI companies founded by purely tech professionals often opt to bring in pharma executives with insider knowledge further down the line.

Pharma Companies 52

Pharma Companies Drugs In-Vivo Genetics 52

pharmaphorum

DECEMBER 16, 2020

Soon the ABPI and the entire industry were facing the ripple effects of COVID-19, including a significant slowdown in non-COVID clinical research, which Torbett says was challenging for the industry to deal with. “We’ve “It’s been a very interesting year to kick things off.”. A collaborative future.

Vaccination 121

Vaccination Vaccine Life Science In-Vitro 121

pharmaphorum

AUGUST 31, 2021

Christopher Boone, global head of health economics and outcomes research at AbbVie, advises: “Evidence generation in drug development is ripe for innovation in the digital era and the expanded use of real-world evidence presents a clear enabler to saving time and money. It is true that RWD contains more potential bias as a result.

Clinical Trials 80

Clinical Trials Clinical Trials Life Science Trials 80

XTalks

SEPTEMBER 5, 2023

Finally, addressing the time-consuming and costly transition from non-clinical to clinical development due to difficulties in predicting human immune responses is another issue. Patient advocacy groups have raised awareness of the health issues and the impact of clinical research in improving their quality of life.

Vaccination 96

Vaccination Vaccine Development Clinical Trials 96

pharmaphorum

DECEMBER 21, 2021

Additionally, the work being done within Rare Disease networks, formed of specialty sites, pharma companies, CROs, researchers, and other stakeholders, can all benefit from the value generated by real world genomic data, as outlined by panellist Dr Joanne Hackett, Head of Genomic and Precision medicine at IQVIA.

Development 98

Development Genome Genomics Drugs 98

pharmaphorum

APRIL 7, 2021

With other drugs in the pipeline too, van de Winkel said the company aims to continue to break new ground with next-generation antibody-based therapies. He notes that it already has 21 partnerships with pharma companies and will aim to keep more product rights than it did in the past. In good shape. We are in a crisis.

Antibody 78

Antibody Life Science Development Regulation 78

Cloudbyz

MAY 19, 2021

Market Landscape: Build, Buy, or Partner The stakes in the CGT industry are relatively high for success and every bio-pharma company wants to be the pioneer with patents and ready-to-commercialized products (especially in the trending T-cell and viral vector domain).

Gene Therapy 52

Gene Therapy Gene Manufacturing Production 52

XTalks

MAY 6, 2022

Clinical data management is important because the data that is collected needs to be accurate, complete and properly analyzed in a timely manner. The advantages of good clinical data management software systems include: Fast data access: Using an advanced clinical data management platform helps pharma companies be more efficient.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Life Science 98

The Pharma Data

DECEMBER 17, 2020

Martin Carter Professor in Clinical Investigation and Head of the Laboratory of Investigative Dermatology at The Rockefeller University and Weinblatt is the co-director of Clinical Rheumatology at the Brigham and Women’s Hospital. AB2 Bio – Swiss pharma company AB2 Bio Ltd. Immune Regulation – U.K.-based

Development 52

Development Gene Therapy Engineer Life Science 52

XTalks

MAY 11, 2023

Now it’s regulators, payers, academics, patient communities, physicians and industry all asking, “Where have you incorporated the patient voice? The need to develop points in time where patient insights can inform clinical research is really critical. Where have you asked caregivers about what really matters?

Clinical Trials 97

Clinical Trials Clinical Trials Trials Development 97

pharmaphorum

OCTOBER 18, 2021

There was a genuine sense of alliance; regulatory bodies and pharma companies coming together to accelerate processes and find the most optimal model for collaboration. What remains very clear is that collaboration between sponsor companies, health authorities and other stakeholders will be required to move this forward.

Vaccination 142

Vaccination Vaccine Regulation Medicine 142

pharmaphorum

MAY 26, 2022

Inadequate clinical trial representations of all populations can therefore leave underrepresented groups vulnerable due to the lack of subgroup-specific data. While many pharma companies are actively working on initiatives to improve diversity in clinical trials, we still have a long way to go.

Clinical Trials 143

Clinical Trials Clinical Trials Trials Medicine 143

pharmaphorum

MARCH 12, 2021

That was the message from ‘The New Normal: Balancing the rapid evolution of trial design with patient need’ panel at the NIHR’s Clinical Research Network Virtual Event on Delivering Complex and Innovative Design (CID) Studies. Thankfully, many pharma companies seem to be gradually improving on this. Listening to patients.

Trials 131

Trials Research Pharma Companies Clinical Trials 131

pharmaphorum

NOVEMBER 3, 2022

Beyond digital clinical measures, digital solutions are maturing to address major challenges facing clinical research and offer enormous promise to support the key performance indicators (KPIs) for every member of our industry. Pharma companies with more mature digital strategies are able to focus on questions of scale.

Clinical Trials 81

Clinical Trials Clinical Trials Trials Medicine 81

pharmaphorum

FEBRUARY 16, 2022

While randomised clinical trials remain the gold standard for testing medicines, showing how they perform in real-world settings is gaining increasing importance for both regulators and payers. Eversana push into RWD gathered momentum last year when it launched a data management and analysis platform for chronic diseases.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Pharma Companies 52

pharmaphorum

SEPTEMBER 1, 2020

.” This public-spirited industry still required greater oversight, however, and government regulations on medicines increased on both sides of the Atlantic. Thalidomide and the development of drug safety regulation and monitoring. George Merck on the cover of Time magazine.

Medicine 145

Medicine Insulin Pharmacy Drugs 145

pharmaphorum

DECEMBER 22, 2021

The ‘PEP Talks’ monthly e-newsletter has approaching 50 pharma companies as subscribers and the inaugural ‘Patient Engagement Day’ on September 01 st achieved an inspirational number of downloads of toolkits for ways to ‘Amplify the Patient Voice’ as the launch theme.

Clinical Trials 104

Clinical Trials Clinical Trials Trials Pharma Companies 104

pharmaphorum

DECEMBER 15, 2022

For health innovation, digital transformation in the NHS – using digital technology to change and improve services and outcomes for patients, including primary care records, legacy items, and clinical research – is critical. After all, the clinical trial environment in the UK is deteriorating, she said.

Life Science 97

Life Science Medicine Clinical Trials Clinical Trials 97

XTalks

OCTOBER 1, 2020

Lin has made several transitions throughout her career, from being a clinician at an academic center, to academic research, to heading business development in industry. However, within industry organizations such as large pharma companies, funding tends to differ at each stage of research and development.

Scientist 52

Scientist In-Vitro Research Life Science 52

Pharmaceutical Technology

APRIL 12, 2023

While multiple testing labs that use non-human primates for research were contacted for this article, all declined to comment amidst the most recent news coverage. This is to ensure patient safety, as outlined in The Medicines for Human Use (Clinical Trials) Regulations 2004.

Regulation 245

Regulation Vaccination Vaccine Medicine 245

pharmaphorum

NOVEMBER 15, 2021

.” After his 11-month stint heading the agency, Califf returned to his role as a cardiologist whilst also serving as a health policy and strategy advisor to Google’s unit life sciences unit Verily and running Duke University’s Clinical Research Institute, which he founded in 1996.

Regulation 98

Regulation Life Science Pharma Companies Branding 98